Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Colon Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02908451
What this trial is testing

AbGn-107 in Patients With Gastric, Colorectal, Pancreatic or Biliary Cancer

Who this might be right for
Gastric CancerColorectal CancerPancreatic Cancer+1 more
AbGenomics B.V Taiwan Branch 39
Not applicableUnknownNCT02942238
What this trial is testing

Standardization of Laparoscopic Surgery for Right Hemi Colon Cancer (SLRC)

Who this might be right for
Overall SurvivalPostoperative ComplicationsMetastasis+1 more
Ruijin Hospital 582
Testing effectiveness (Phase 2)Study completedNCT00003225
What this trial is testing

Amifostine Plus Irinotecan in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jonsson Comprehensive Cancer Center 23
Not applicableLooking for participantsNCT06698146
What this trial is testing

Colorectal Metastasis to Liver Extraction With Auxiliary Transplant and Delayed Resection

Who this might be right for
Liver Transplant SurgeryColorectal Cancer MetastaticColon Cancer Liver Metastases
Northwestern University 80
Large-scale testing (Phase 3)Study completedNCT00056446
What this trial is testing

Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColonic NeoplasmsRectal Neoplasms
Novartis Pharmaceuticals 855
Testing effectiveness (Phase 2)Ended earlyNCT01605318
What this trial is testing

Study of Labetuzumab Govitecan in Participants With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal CancerColon CancerRectal Cancer
Gilead Sciences 92
Large-scale testing (Phase 3)Study completedNCT01931150
What this trial is testing

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Who this might be right for
Cetuximab-induced Papulopustular (Acneiform) Rash Who HaveMetastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma
Memorial Sloan Kettering Cancer Center 11
Not applicableWithdrawnNCT06221423
What this trial is testing

Fruquintinib Combined With TAS-102 in Refractory Metastatic Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Colorectal CancerRefractory Colorectal Carcinoma
Fudan University
Not applicableStudy completedNCT00896896
What this trial is testing

Immunoreactivity to Cetuximab in Cancer Patients

Who this might be right for
Colorectal CancerHead and Neck Cancer
Vanderbilt-Ingram Cancer Center 538
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Large-scale testing (Phase 3)UnknownNCT02402972
What this trial is testing

A Multi-center Randomized Controlled Trial of Intraportal Chemotherapy Combined With Adjuvant Chemotherapy (mFOLFOX6) for Stage II and III Colon Cancer

Who this might be right for
Colorectal CancerMetastasis
Xu jianmin 700
Not applicableLooking for participantsNCT06227728
What this trial is testing

Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.

Who this might be right for
Non Small Cell Lung CancerBreast CancerColorectal Cancer+4 more
Gene Solutions 50
Testing effectiveness (Phase 2)Looking for participantsNCT06244771
What this trial is testing

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Who this might be right for
Advanced Solid Tumors With KRAS G12C MutationsSolid Tumor, AdultUnresectable Solid Tumor+5 more
Frontier Medicines Corporation 403
Testing effectiveness (Phase 2)Active Not RecruitingNCT04294264
What this trial is testing

TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer

Who this might be right for
Metastatic Colorectal CarcinomaRecurrent Colon CarcinomaRefractory Colorectal Carcinoma+3 more
Rutgers, The State University of New Jersey 50
Testing effectiveness (Phase 2)Study completedNCT00103298
What this trial is testing

Isolated Hepatic Perfusion With Melphalan Followed by Combination Chemotherapy in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01183663
What this trial is testing

Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 180
Not applicableLooking for participantsNCT04959604
What this trial is testing

Lymph Node Mapping Via Flourescent Dye in Colon Cancer

Who this might be right for
Colon CarcinomaLymph Node Metastases
Universitätsklinikum Hamburg-Eppendorf 30
Early research (Phase 1)Study completedNCT00005616
What this trial is testing

Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 12
Early research (Phase 1)Study completedNCT04164069
What this trial is testing

Dasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without Bevacizumab

Who this might be right for
Advanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more
Anne Noonan 9
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Next Page